Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
RMD Open|January 23, 2023
Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung diseaseTakayuki Niitsu, Kiyoharu Fukushima, Sho Komukai, et al.
Emerging Infectious Diseases|March 2, 2025
Identification of 2 Novel Species, Mycobacterium novusgordonae and M. shingordonaeKazuki Hashimoto, Yuko Abe, Kiyoharu Fukushima, et al.
BMC Infectious Diseases|June 24, 2022
Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severityYuichi Maeda, Daisuke Motooka, Takahiro Kawasaki, et al.
Journal of Clinical Microbiology|March 22, 2023
MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective StudyKiyoharu Fukushima, Yuki Matsumoto, Takanori Matsuki, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2024
Variability of macrolide-resistant profile in <i>Mycobacterium avium</i> complex pulmonary diseaseKiyoharu Fukushima, Yuki Matsumoto, Yuko Abe, et al.
International Immunology|April 24, 2026
Distinct fibrosis-associated macrophage subsets coordinate iron metabolism in pulmonary fibrosisHiroshi Nabeshima, Kiyoharu Fukushima, Yu-Chen Liu, et al.
Inflammation and Regeneration|December 1, 2022
Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19Takahiro Kawasaki, Yoshito Takeda, Ryuya Edahiro, et al.
The Journal of Allergy and Clinical Immunology. Global|March 6, 2025
Potential asthma biomarkers identified by nontargeted proteomics of extracellular vesicles in exhaled breath condensateReina Hara, Yoshito Takeda, Takatoshi Enomoto, et al.
Respiratory Research|April 24, 2025
Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung diseaseTakatoshi Enomoto, Yoshito Takeda, Yuya Shirai, et al.
Nature Communications|August 22, 2022
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task ForceQingbo S Wang, Ryuya Edahiro, Ho Namkoong, et al.
Pageof 4